Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues - PubMed (original) (raw)

. 2012 Nov;44(11):1207-14.

doi: 10.1038/ng.2442. Epub 2012 Oct 14.

Netta Mendelson Cohen, Zohar Mukamel, Amir Bar, Alina Molchadsky, Ran Brosh, Shirley Horn-Saban, Daniela Amann Zalcenstein, Naomi Goldfinger, Adi Zundelevich, Einav Nili Gal-Yam, Varda Rotter, Amos Tanay

Affiliations

• PMID: 23064413
• DOI: 10.1038/ng.2442

Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues

Gilad Landan et al. Nat Genet. 2012 Nov.

Abstract

DNA methylation has been comprehensively profiled in normal and cancer cells, but the dynamics that form, maintain and reprogram differentially methylated regions remain enigmatic. Here, we show that methylation patterns within populations of cells from individual somatic tissues are heterogeneous and polymorphic. Using in vitro evolution of immortalized fibroblasts for over 300 generations, we track the dynamics of polymorphic methylation at regions developing significant differential methylation on average. The data indicate that changes in population-averaged methylation occur through a stochastic process that generates a stream of local and uncorrelated methylation aberrations. Despite the stochastic nature of the process, nearly deterministic epigenetic remodeling emerges on average at loci that lose or gain resistance to methylation accumulation. Changes in the susceptibility to methylation accumulation are correlated with changes in histone modification and CTCF occupancy. Characterizing epigenomic polymorphism within cell populations is therefore critical to understanding methylation dynamics in normal and cancer cells.

PubMed Disclaimer

Comment in

• Tracking the evolution of cancer methylomes.
  Krebs AR, Schübeler D. Krebs AR, et al. Nat Genet. 2012 Nov;44(11):1173-4. doi: 10.1038/ng.2451. Nat Genet. 2012. PMID: 23104061

Similar articles

• Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
  De La Rosa-Velázquez IA, Rincón-Arano H, Benítez-Bribiesca L, Recillas-Targa F. De La Rosa-Velázquez IA, et al. Cancer Res. 2007 Mar 15;67(6):2577-85. doi: 10.1158/0008-5472.CAN-06-2024. Cancer Res. 2007. PMID: 17363576
• Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
  Paradowska A, Fenic I, Konrad L, Sturm K, Wagenlehner F, Weidner W, Steger K. Paradowska A, et al. Int J Oncol. 2009 Jul;35(1):87-96. doi: 10.3892/ijo_00000316. Int J Oncol. 2009. PMID: 19513555
• Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
  Chang JW, Hsu HS, Ni HJ, Chuang CT, Hsiung CH, Huang TH, Wang YC. Chang JW, et al. PLoS One. 2010 Sep 20;5(9):e12847. doi: 10.1371/journal.pone.0012847. PLoS One. 2010. PMID: 20877461 Free PMC article.
• DNA methylation patterns in lung carcinomas.
  Pfeifer GP, Rauch TA. Pfeifer GP, et al. Semin Cancer Biol. 2009 Jun;19(3):181-7. doi: 10.1016/j.semcancer.2009.02.008. Epub 2009 Feb 20. Semin Cancer Biol. 2009. PMID: 19429482 Free PMC article. Review.
• Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.
  Recillas-Targa F, De La Rosa-Velázquez IA, Soto-Reyes E, Benítez-Bribiesca L. Recillas-Targa F, et al. J Cell Mol Med. 2006 Jul-Sep;10(3):554-68. doi: 10.1111/j.1582-4934.2006.tb00420.x. J Cell Mol Med. 2006. PMID: 16989720 Free PMC article. Review.

Cited by

• DNA methylation in mammalian development and disease.
  Smith ZD, Hetzel S, Meissner A. Smith ZD, et al. Nat Rev Genet. 2024 Aug 12. doi: 10.1038/s41576-024-00760-8. Online ahead of print. Nat Rev Genet. 2024. PMID: 39134824 Review.
• Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer.
  O'Keefe CM, Zhao Y, Cope LM, Ho CM, Fader AN, Stone R, Ferris JS, Beavis A, Levinson K, Wethington S, Wang TL, Pisanic TR, Shih IM, Wang TH. O'Keefe CM, et al. Clin Transl Med. 2024 Aug;14(8):e1778. doi: 10.1002/ctm2.1778. Clin Transl Med. 2024. PMID: 39083293 Free PMC article.
• Age Prediction Using DNA Methylation Heterogeneity Metrics.
  Karetnikov DI, Romanov SE, Baklaushev VP, Laktionov PP. Karetnikov DI, et al. Int J Mol Sci. 2024 May 2;25(9):4967. doi: 10.3390/ijms25094967. Int J Mol Sci. 2024. PMID: 38732187 Free PMC article.
• On epigenetic stochasticity, entropy and cancer risk.
  Teschendorff AE. Teschendorff AE. Philos Trans R Soc Lond B Biol Sci. 2024 Apr 22;379(1900):20230054. doi: 10.1098/rstb.2023.0054. Epub 2024 Mar 4. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38432318 Free PMC article. Review.
• Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.
  Ulrich A, Wu Y, Draisma H, Wharton J, Swietlik EM, Cebola I, Vasilaki E, Balkhiyarova Z, Jarvelin MR, Auvinen J, Herzig KH, Coghlan JG, Lordan J, Church C, Howard LS, Pepke-Zaba J, Toshner M, Wort SJ, Kiely DG, Condliffe R, Lawrie A, Gräf S, Morrell NW, Wilkins MR, Prokopenko I, Rhodes CJ. Ulrich A, et al. Nat Commun. 2024 Jan 6;15(1):330. doi: 10.1038/s41467-023-44683-0. Nat Commun. 2024. PMID: 38184627 Free PMC article.

References

1. 1. Blood. 2011 Jan 6;117(1):e1-14 - PubMed
2. 1. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4828-33 - PubMed
3. 1. Cancer Cell. 2010 May 18;17(5):510-22 - PubMed
4. 1. Cancer Cell. 2011 Nov 15;20(5):606-19 - PubMed
5. 1. Nature. 2010 Aug 26;466(7310):1129-33 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations